<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" lang="" xml:lang="">
<head>
  <meta charset="utf-8" />
  <meta name="generator" content="pandoc" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0, user-scalable=yes" />
  <title>KSI.TO</title>
  <style>
    /* Default styles provided by pandoc.
    ** See https://pandoc.org/MANUAL.html#variables-for-html for config info.
    */
    html {
      color: #1a1a1a;
      background-color: #fdfdfd;
    }
    body {
      margin: 0 auto;
      max-width: 36em;
      padding-left: 50px;
      padding-right: 50px;
      padding-top: 50px;
      padding-bottom: 50px;
      hyphens: auto;
      overflow-wrap: break-word;
      text-rendering: optimizeLegibility;
      font-kerning: normal;
    }
    @media (max-width: 600px) {
      body {
        font-size: 0.9em;
        padding: 12px;
      }
      h1 {
        font-size: 1.8em;
      }
    }
    @media print {
      html {
        background-color: white;
      }
      body {
        background-color: transparent;
        color: black;
        font-size: 12pt;
      }
      p, h2, h3 {
        orphans: 3;
        widows: 3;
      }
      h2, h3, h4 {
        page-break-after: avoid;
      }
    }
    p {
      margin: 1em 0;
    }
    a {
      color: #1a1a1a;
    }
    a:visited {
      color: #1a1a1a;
    }
    img {
      max-width: 100%;
    }
    svg {
      height: auto;
      max-width: 100%;
    }
    h1, h2, h3, h4, h5, h6 {
      margin-top: 1.4em;
    }
    h5, h6 {
      font-size: 1em;
      font-style: italic;
    }
    h6 {
      font-weight: normal;
    }
    ol, ul {
      padding-left: 1.7em;
      margin-top: 1em;
    }
    li > ol, li > ul {
      margin-top: 0;
    }
    blockquote {
      margin: 1em 0 1em 1.7em;
      padding-left: 1em;
      border-left: 2px solid #e6e6e6;
      color: #606060;
    }
    code {
      font-family: Menlo, Monaco, Consolas, 'Lucida Console', monospace;
      font-size: 85%;
      margin: 0;
      hyphens: manual;
    }
    pre {
      margin: 1em 0;
      overflow: auto;
    }
    pre code {
      padding: 0;
      overflow: visible;
      overflow-wrap: normal;
    }
    .sourceCode {
     background-color: transparent;
     overflow: visible;
    }
    hr {
      border: none;
      border-top: 1px solid #1a1a1a;
      height: 1px;
      margin: 1em 0;
    }
    table {
      margin: 1em 0;
      border-collapse: collapse;
      width: 100%;
      overflow-x: auto;
      display: block;
      font-variant-numeric: lining-nums tabular-nums;
    }
    table caption {
      margin-bottom: 0.75em;
    }
    tbody {
      margin-top: 0.5em;
      border-top: 1px solid #1a1a1a;
      border-bottom: 1px solid #1a1a1a;
    }
    th {
      border-top: 1px solid #1a1a1a;
      padding: 0.25em 0.5em 0.25em 0.5em;
    }
    td {
      padding: 0.125em 0.5em 0.25em 0.5em;
    }
    header {
      margin-bottom: 4em;
      text-align: center;
    }
    #TOC li {
      list-style: none;
    }
    #TOC ul {
      padding-left: 1.3em;
    }
    #TOC > ul {
      padding-left: 0;
    }
    #TOC a:not(:hover) {
      text-decoration: none;
    }
    code{white-space: pre-wrap;}
    span.smallcaps{font-variant: small-caps;}
    div.columns{display: flex; gap: min(4vw, 1.5em);}
    div.column{flex: auto; overflow-x: auto;}
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
    /* The extra [class] is a hack that increases specificity enough to
       override a similar rule in reveal.js */
    ul.task-list[class]{list-style: none;}
    ul.task-list li input[type="checkbox"] {
      font-size: inherit;
      width: 0.8em;
      margin: 0 0.8em 0.2em -1.6em;
      vertical-align: middle;
    }
    .display.math{display: block; text-align: center; margin: 0.5rem auto;}
  </style>
</head>
<body>
<h1 id="kneat.com-inc.-tsx-ksi">kneat.com, inc. (TSX: KSI)</h1>
<h2 id="business-summary">Business summary</h2>
<ul>
<li>Developer of Kneat Gx, a configurable SaaS platform that digitizes
validation lifecycle and related GxP workflows for life sciences
(biotech, pharma, medical devices)</li>
<li>Differentiators: no‑code configurability, compliance-ready data
integrity (FDA 21 CFR Part 11, EU Annex 11), ISO 9001 and ISO 27001
certifications</li>
<li>Go-to-market: land-and-expand with enterprise customers; recurring
SaaS plus professional services; growing partner ecosystem (tiered
partners and GSIs)</li>
<li>Strategic focus: scale within existing accounts, accelerate new logo
wins, and extend platform toward broader quality management</li>
<li>Target market opportunity estimated at &gt;US$2B ARR within
regulated industries</li>
</ul>
<h2 id="recent-developments">Recent developments</h2>
<ul>
<li>Partnered with Capgemini to accelerate enterprise-wide deployments
and core system integrations (Jan 2025)</li>
<li>New wins: EU specialty therapeutics (CQV), global consumer products
health division (validation), generics pharma (drawing management),
clinical diagnostics leader (equipment validation), global healthcare
technology company (multi‑year MSA for CQV and CSV)</li>
<li>Product: launched Kneat Gx 9.5 (July 2025) to advance data reuse,
risk-based validation (e.g., CSA), and real-time adaptable
workflows</li>
<li>Executive changes: CFO transition to Dave O’Reilly; created Chief
Innovation Officer role (Kevin Fitzgerald) and appointed new CPO (Donal
O’Sullivan)</li>
<li>Community: record attendance at VALIDATE 2025 event for validation
and quality professionals</li>
</ul>
<h2 id="key-issues">Key issues</h2>
<ul>
<li>Currency exposure: material FX impacts on results; no hedging
program; revenues/costs largely in EUR/USD while reporting in CAD</li>
<li>Customer concentration and sales cycle: top 10 customers = 51% of
revenue (H1 2025); enterprise sales and scale-ups can be lumpy</li>
<li>Scaling and cost discipline: continued investment in R&amp;D and
go-to-market while progressing toward sustainable profitability</li>
<li>Reliance on third-parties and security: cloud hosting and other
critical systems pose operational and cybersecurity risks</li>
<li>Leverage and rates: IPF facility (EURIBOR + 7% cash interest + 2%
PIK) with minimum cash covenant (currently €6m) exposes company to
interest-rate and covenant risks</li>
<li>Macro/trade uncertainties and competitive dynamics in validation/QMS
software markets</li>
</ul>
<h2 id="financial-summary-cad-000s-except-ratios-and-arr">Financial
summary (CAD ‘000s, except ratios and ARR)</h2>
<table style="width:100%;">
<colgroup>
<col style="width: 39%" />
<col style="width: 10%" />
<col style="width: 10%" />
<col style="width: 10%" />
<col style="width: 10%" />
<col style="width: 10%" />
<col style="width: 10%" />
</colgroup>
<thead>
<tr>
<th>Metric</th>
<th style="text-align: right;">Q2 2025</th>
<th style="text-align: right;">Q2 2024</th>
<th style="text-align: right;">H1 2025</th>
<th style="text-align: right;">H1 2024</th>
<th style="text-align: right;">FY 2024</th>
<th style="text-align: right;">FY 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>Revenue (total)</td>
<td style="text-align: right;">15,405</td>
<td style="text-align: right;">11,676</td>
<td style="text-align: right;">30,153</td>
<td style="text-align: right;">22,443</td>
<td style="text-align: right;">48,938</td>
<td style="text-align: right;">34,223</td>
</tr>
<tr>
<td>Gross Profit</td>
<td style="text-align: right;">11,627</td>
<td style="text-align: right;">8,694</td>
<td style="text-align: right;">22,552</td>
<td style="text-align: right;">16,627</td>
<td style="text-align: right;">36,759</td>
<td style="text-align: right;">23,132</td>
</tr>
<tr>
<td>Gross Margin %</td>
<td style="text-align: right;">75%</td>
<td style="text-align: right;">74%</td>
<td style="text-align: right;">75%</td>
<td style="text-align: right;">74%</td>
<td style="text-align: right;">75%</td>
<td style="text-align: right;">68%</td>
</tr>
<tr>
<td>Operating Income (Loss) (EBIT)</td>
<td style="text-align: right;">(3,998)</td>
<td style="text-align: right;">(2,632)</td>
<td style="text-align: right;">(5,400)</td>
<td style="text-align: right;">(4,882)</td>
<td style="text-align: right;">(5,947)</td>
<td style="text-align: right;">(13,934)</td>
</tr>
<tr>
<td>EBITDA</td>
<td style="text-align: right;">(660)</td>
<td style="text-align: right;">248</td>
<td style="text-align: right;">961</td>
<td style="text-align: right;">23</td>
<td style="text-align: right;">4,188</td>
<td style="text-align: right;">(6,320)</td>
</tr>
<tr>
<td>Adjusted EBITDA</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">N/A</td>
</tr>
<tr>
<td>Finance expense</td>
<td style="text-align: right;">878</td>
<td style="text-align: right;">871</td>
<td style="text-align: right;">1,766</td>
<td style="text-align: right;">1,738</td>
<td style="text-align: right;">3,665</td>
<td style="text-align: right;">1,082</td>
</tr>
<tr>
<td>Net income (loss)</td>
<td style="text-align: right;">(379)</td>
<td style="text-align: right;">(3,100)</td>
<td style="text-align: right;">1,767</td>
<td style="text-align: right;">(6,437)</td>
<td style="text-align: right;">(7,727)</td>
<td style="text-align: right;">(14,520)</td>
</tr>
<tr>
<td>SaaS revenue</td>
<td style="text-align: right;">14,145</td>
<td style="text-align: right;">10,835</td>
<td style="text-align: right;">27,951</td>
<td style="text-align: right;">20,554</td>
<td style="text-align: right;">44,570</td>
<td style="text-align: right;">30,067</td>
</tr>
<tr>
<td>Professional services &amp; other</td>
<td style="text-align: right;">1,242</td>
<td style="text-align: right;">777</td>
<td style="text-align: right;">2,162</td>
<td style="text-align: right;">1,755</td>
<td style="text-align: right;">4,046</td>
<td style="text-align: right;">3,443</td>
</tr>
<tr>
<td>Cash from operating activities</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">15,548</td>
<td style="text-align: right;">10,030</td>
<td style="text-align: right;">9,790</td>
<td style="text-align: right;">(331)</td>
</tr>
<tr>
<td>Capital expenditures (capex)</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">10,696</td>
<td style="text-align: right;">9,726</td>
<td style="text-align: right;">19,882</td>
<td style="text-align: right;">18,060</td>
</tr>
<tr>
<td>Free Cash Flow (approx)</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">N/A</td>
<td style="text-align: right;">4,852</td>
<td style="text-align: right;">304</td>
<td style="text-align: right;">(10,092)</td>
<td style="text-align: right;">(18,391)</td>
</tr>
<tr>
<td>ARR (period-end)</td>
<td style="text-align: right;">64,800</td>
<td style="text-align: right;">45,400</td>
<td style="text-align: right;">64,800</td>
<td style="text-align: right;">45,400</td>
<td style="text-align: right;">59,700</td>
<td style="text-align: right;">37,400</td>
</tr>
<tr>
<td>Cash (end of period)</td>
<td style="text-align: right;">66,772</td>
<td style="text-align: right;">35,893</td>
<td style="text-align: right;">66,772</td>
<td style="text-align: right;">35,893</td>
<td style="text-align: right;">58,890</td>
<td style="text-align: right;">15,253</td>
</tr>
<tr>
<td>SaaS revenue (% of total)</td>
<td style="text-align: right;">91.8%</td>
<td style="text-align: right;">92.8%</td>
<td style="text-align: right;">92.7%</td>
<td style="text-align: right;">91.6%</td>
<td style="text-align: right;">91.1%</td>
<td style="text-align: right;">87.9%</td>
</tr>
</tbody>
</table>
<p>Notes:</p>
<ul>
<li>Sources: Unaudited condensed interim consolidated financial
statements and MD&amp;A for the three and six months ended June 30,
2025; Audited consolidated financial statements and MD&amp;A for the
year ended December 31, 2024 (CAD).</li>
<li>EBITDA calculation:
<ul>
<li>EBITDA = Operating income (loss) + Depreciation + Amortization.</li>
<li>Q2 2025: (-3,997.5) + 181.7 + 3,155.6 ≈ -660.2</li>
<li>Q2 2024: (-2,631.7) + 190.4 + 2,688.9 ≈ 247.6</li>
<li>H1 2025: (-5,399.8) + 358.7 + 6,002.4 ≈ 961.3</li>
<li>H1 2024: (-4,881.6) + 381.6 + 4,523.1 ≈ 23.1</li>
<li>FY 2024: (-5,947.4) + 745.6 + 9,389.3 ≈ 4,188</li>
<li>FY 2023: (-13,934.2) + 786.1 + 6,828.2 ≈ -6,320</li>
</ul></li>
<li>Capex approximation: intangible additions (cash) + PPE additions.
<ul>
<li>FY 2024: 19,716.6 + 165.6 ≈ 19,882.2</li>
<li>FY 2023: 17,879.0 + 181.4 ≈ 18,060.4</li>
</ul></li>
<li>Free Cash Flow approximation: CFO – Capex.</li>
</ul>
<h2 id="capitalization-cash-debt-and-enterprise-value">Capitalization,
Cash, Debt, and Enterprise Value</h2>
<table>
<colgroup>
<col style="width: 44%" />
<col style="width: 55%" />
</colgroup>
<thead>
<tr>
<th>Item</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>Stock Price</td>
<td>$6.08 CAD</td>
</tr>
<tr>
<td>Basic Shares (pro forma, Aug 5, 2025)</td>
<td>95,018,978</td>
</tr>
<tr>
<td>Fully Diluted Shares (TSM + RSUs + DSUs)</td>
<td>98,210,108</td>
</tr>
<tr>
<td>Implied Market Cap (Basic)</td>
<td>$577.7m CAD</td>
</tr>
<tr>
<td>Implied Market Cap (Fully Diluted)</td>
<td>$597.1m CAD</td>
</tr>
<tr>
<td>Cash (Jun 30, 2025)</td>
<td>$66.8m CAD</td>
</tr>
<tr>
<td>Debt – Loan Payable incl. accrued interest (Jun 30, 2025)</td>
<td>$23.35m CAD</td>
</tr>
<tr>
<td>Lease Liabilities (IFRS 16, total) (Jun 30, 2025)</td>
<td>$7.31m CAD</td>
</tr>
<tr>
<td>Net Debt (excl. leases)</td>
<td>($43.4m) CAD</td>
</tr>
<tr>
<td>EV (Basic, excl. leases)</td>
<td>$534.3m CAD</td>
</tr>
<tr>
<td>EV (Fully Diluted, excl. leases)</td>
<td>$553.7m CAD</td>
</tr>
<tr>
<td>EV (Basic, incl. leases)</td>
<td>$541.6m CAD</td>
</tr>
<tr>
<td>EV (Fully Diluted, incl. leases)</td>
<td>$561.0m CAD</td>
</tr>
</tbody>
</table>
<p>Notes:</p>
<ul>
<li>Dollars in CAD. Sources: Unaudited Condensed Interim Consolidated FS
and MD&amp;A for the period ended June 30, 2025; “Outstanding Share
Information” as of Aug 5, 2025.</li>
<li>Basic shares: 95,018,978 as of Aug 5, 2025 (vs. 95,000,231 at Jun
30, 2025).</li>
<li>Fully diluted shares: Basic + in‑the‑money options (treasury stock
method) + RSUs + DSUs.
<ul>
<li>Options (Aug 5, 2025): 775,922 outstanding, avg strike $3.36; stock
$6.08 → incremental shares = N × (S−K)/S = 775,922 × (6.08−3.36)/6.08 =
775,922 × 17/38 = 347,123.</li>
<li>RSUs (Aug 5, 2025): 2,161,379 (zero‑strike; add in full).</li>
<li>DSUs (Aug 5, 2025): 682,628 (zero‑strike; add in full).</li>
<li>Fully diluted = 95,018,978 + 347,123 + 2,161,379 + 682,628 =
98,210,108.</li>
<li>Small pending issuances for legend removal noted in filings are
immaterial to totals and likely reflected in the Aug 5 share count; if
not, they would add up to ~15k shares.</li>
</ul></li>
<li>Market caps:
<ul>
<li>Basic: 95,018,978 × $6.08 = $577.7m.</li>
<li>Fully diluted: 98,210,108 × $6.08 = $597.1m.</li>
</ul></li>
<li>Cash and debt:
<ul>
<li>Cash: $66.772m (Jun 30, 2025).</li>
<li>Loan payable incl. accrued interest: $23.350m (current +
non‑current, Jun 30, 2025).</li>
<li>Lease liabilities (IFRS 16): $7.313m (current + non‑current, Jun 30,
2025). Analysts vary on including leases in EV; both views shown.</li>
</ul></li>
<li>Enterprise Value formulas:
<ul>
<li>EV (excl. leases) = Equity Value + Loan Debt − Cash.</li>
<li>EV (incl. leases) = Equity Value + (Loan Debt + Lease Liabilities) −
Cash.</li>
</ul></li>
<li>Pro‑forma adjustments after quarter‑end:
<ul>
<li>Share count updated to Aug 5, 2025 (basic increase of ~18.7k vs. Jun
30).</li>
<li>No disclosed post‑quarter financings or debt changes that would
affect cash/debt; therefore EV uses Jun 30, 2025 balance sheet
figures.</li>
</ul></li>
</ul>
<h2 id="valuation">Valuation</h2>
<table>
<thead>
<tr>
<th>Metric</th>
<th>Basic</th>
<th>Fully Diluted</th>
</tr>
</thead>
<tbody>
<tr>
<td>EV/EBIT</td>
<td>NM</td>
<td>NM</td>
</tr>
<tr>
<td>EV/adjusted EBITDA</td>
<td>104.2x</td>
<td>108.0x</td>
</tr>
<tr>
<td>EV/unlevered FCF</td>
<td>NM</td>
<td>NM</td>
</tr>
</tbody>
</table>
<p>Notes:</p>
<ul>
<li>LTM period used: TTM ended June 30, 2025, computed as FY 2024 + H1
2025 − H1 2024 (all CAD ‘000s).
<ul>
<li>LTM EBIT ≈ (-5,947) + (-5,400) − (−4,882) = −6,466 → EV/EBIT not
meaningful (NM).</li>
<li>FY 2024 D&amp;A = 745.6 (PPE) + 9,389.3 (intangible) = 10,135.0; FY
2024 EBITDA = (−5,947.4) + 10,135.0 ≈ 4,188.</li>
<li>LTM EBITDA ≈ 4,188 + 961 − 23 ≈ 5,126. Adjusted EBITDA not
disclosed; EBITDA used per instructions.</li>
<li>FY 2024 Capex (cash) ≈ 19,716.6 (intangible additions) + 165.6 (PPE)
= 19,882.2.</li>
<li>FY 2024 FCF ≈ 9,790.2 (CFO) − 19,882.2 ≈ −10,092.0.</li>
<li>LTM FCF ≈ (−10,092) + 4,852 − 304 ≈ −5,544.</li>
<li>LTM Finance expense ≈ 3,665 + 1,766 − 1,738 ≈ 3,693.</li>
<li>LTM Unlevered FCF ≈ LTM FCF + LTM finance expense ≈ −5,544 + 3,693 ≈
−1,851 → EV/UFCF NM.</li>
</ul></li>
<li>EVs used:
<ul>
<li>Basic EV (excl. leases) = $534.3m; Fully Diluted EV (excl. leases) =
$553.7m (from Capitalization section).</li>
<li>EV/EBITDA (Basic) ≈ 534,300 / 5,126 ≈ 104.2x; EV/EBITDA (FD) ≈
553,700 / 5,126 ≈ 108.0x.</li>
</ul></li>
<li>Units: Financial metrics in CAD ‘000s; EV and market caps in CAD
millions.</li>
<li>Capex is approximated as cash additions to internally developed
software (intangible additions) plus PPE additions, consistent with
prior notes.</li>
<li>“NM” indicates not meaningful due to negative denominator.</li>
</ul>
</body>
</html>
